Clinical Trial Update: Super Selective Adrenal Artery Embolization for Primary Aldosteronism: a Prospective Cohort Study(SAAE-PA)

View source ↗

Summary

This entry reports a recruiting clinical trial (NCT06513676) evaluating super selective adrenal artery embolization as a treatment for primary aldosteronism.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aldosteronism

Snippet

Sponsor: Xinjiang Medical University | Conditions: Primary Aldosteronism, Super Selective Adrenal Arterial Embolization | Status: RECRUITING